ARCHIVES

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

This article is from The Cancer Letter archive.

Vol. 31 No. 10 | March 11, 2005

Download PDF Visit The Full Archive

Related Articles

DCPC Concepts Approved For Tw Grants Support Contract

January 31, 1986

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

July 27, 2001

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

NCI Advisory Group, Other Cancer Meetings For May, June

April 30, 1976

USC $2.5 Million contract Tops Last Minute FY 75 Rush of Awards

July 18, 1975